(Allergan plc)

	AGN latest price $214.9516 (-1.02%) ($214.7393 - $223.1845) on Wed. May. 11, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.82% (three month average)
RSI	45
Latest Price	$214.9516(-1.02%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.8% a day on average for past five trading days.
Weekly Trend	AGN declines -2% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -1.41% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-13%)    SHY(-4%)    IPO(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.41% (StdDev 2.82%)
Hourly BBV	0 ()
Intraday Trend	-0.9%

1 - 5 Day Possible Target	$202.58(-5.76%)
5 Day Moving Average	$207.2(3.74%)
10 Day Moving Average	$208.15(3.27%)
20 Day Moving Average	$211.45(1.66%)
To recent high	-25.5%
To recent low	10.4%
Market Cap	$70.87b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed